ReWalk Robotics (LFWD) to Release Earnings on Tuesday

ReWalk Robotics (NASDAQ:LFWD) is scheduled to release its earnings data before the market opens on Tuesday, November 12th. Analysts expect ReWalk Robotics to post earnings of ($0.27) per share for the quarter. ReWalk Robotics has set its FY 2024 guidance at EPS.

ReWalk Robotics (NASDAQ:LFWD) last released its earnings results on Thursday, August 15th. The company reported ($0.50) EPS for the quarter, topping analysts’ consensus estimates of ($0.53) by $0.03. ReWalk Robotics had a negative return on equity of 41.89% and a negative net margin of 102.03%. The company had revenue of $6.71 million for the quarter, compared to the consensus estimate of $6.71 million. During the same quarter last year, the business posted ($0.35) EPS. On average, analysts expect ReWalk Robotics to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

ReWalk Robotics Trading Down 3.0 %

Shares of NASDAQ LFWD opened at $2.28 on Wednesday. The company has a market capitalization of $20.00 million, a price-to-earnings ratio of -0.75 and a beta of 2.07. ReWalk Robotics has a twelve month low of $2.20 and a twelve month high of $9.10. The business has a 50 day simple moving average of $2.93 and a 200-day simple moving average of $3.80.

Analysts Set New Price Targets

Separately, HC Wainwright boosted their target price on shares of ReWalk Robotics from $9.00 to $13.00 and gave the company a “buy” rating in a research note on Friday, August 16th.

ReWalk Robotics Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.